Abstract:Arterial thrombosis, which represents a critical complication of cardiovascular diseases, is a leading cause of death and disability worldwide. A symbolic feature of arterial thrombosis is large-scale platelet aggregation due to high shear stress generated by stenosis. However, current hematological tests cannot evaluate arterial thrombosis in such physiological settings. To bridge this gap, we developed a microfluidics-based thrombus profiling assay (Fig. 1A) that combines multi-fluorescence imaging with a stenotic channel design to comprehensively characterize thrombi formed in high shear blood flow (Fig. 1B, C). Thrombi are characterized by a 7-dimensional profile indicating the thrombus size (Plt) and levels of fibrinogen (Fg), VWF, P-selectin, phosphatidylserine (PS) and extended (E + ) and activated α IIb β 3 in the thrombus (Fig. 1D). Using this assay, we discovered intensified thrombus formation in subjects with hypertension and/or aging (Fig. 1D). We also found extended integrin α IIb β 3 as a superior biomarker for platelet hyperreactivity than P-selectin and activated integrin α IIb β 3 and a potential predictor for arterial thrombosis (Fig. 1E). By studying the effects of anti-thrombotic agents NMC4 and 7E3 on hypertension patients’ blood, our work reveals a ‘treatment mismatch’ phenomenon that can seriously affect the efficacy and safety of anti-thrombotic drugs (Fig. 1F). Our findings provide mechanistic insights into the high risk of arterial thrombosis and antiplatelet resistance in populations with hypertension and aging. The discovered ‘treatment mismatch’ heralds a new era in thrombosis management where patients’ thrombus profiles dictate personalized therapeutic decisions to optimize treatment efficacy and reduce adverse outcomes. The outstanding performance of our assay underscores its translational potential for anti-thrombotic drug screening, thrombosis diagnosis, and personalized anti-thrombotic regimen selection.

Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine

Thrombosis formation on atherosclerotic lesions and plaque rupture

Perspectives from Multiscale Computation

Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research

Platelets in Hemostasis and Thrombosis: Novel Mechanisms of Fibrinogen-Independent Platelet Aggregation and Fibronectinmediated Protein Wave of Hemostasis

Multi-parametric thrombus profiling microfluidics detects intensified biomechanical thrombogenesis associated with hypertension and aging

Abstract 153: Multi-parametric Thrombus Profiling Microfluidics Uncovers Mechanobiology of Hypertension and Aging-related Thrombosis

Computer-Based Mechanical Analysis of Stenosed Artery with Thrombotic Plaque: the Influences of Important Physiological Parameters

Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis

Combined Computational Modeling and Experimental Study of the Biomechanical Mechanisms of Platelet-Driven Contraction of Fibrin Clots

Linking Computational Fluid Dynamics Modeling to Device-Induced Platelet Defects in Mechanically Assisted Circulation

Platelets in Thrombosis and Atherosclerosis: A Double-Edged Sword

Role of biomechanical forces in the natural history of coronary atherosclerosis

ENDOTHELIAL MECHANOTRANSDUCTION MECHANISMS FOR VASCULAR PHYSIOLOGY AND ATHEROSCLEROSIS

Mechanobiology of shear-induced platelet aggregation leading to occlusive arterial thrombosis: A multiscale in silico analysis

Review of Mechanical Testing and Modelling of Thrombus Material for Vascular Implant and Device Design

Probing interactions of red blood cells and contracting fibrin platelet clots

Influence of shear rate and surface chemistry on thrombus formation in micro-crevice

Integrating blood cell mechanics, platelet adhesive dynamics and coagulation cascade for modelling thrombus formation in normal and diabetic blood

Biomechanics-mediated endocytosis in atherosclerosis